Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Voyager Therapeutics, Inc. Common Stock, par value $0.001 per share (VYGR).
- Disclosed ownership: 6.1%.
- Date of event: 16 Jan 2026.
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 6.1% ownership in Voyager Therapeutics, Inc. Common Stock, par value $0.001 per share (VYGR) on 16 Jan 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 6% | 3,338,862 | 0 | 3,338,862 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 6.1% | 3,407,969 | 0 | 3,407,969 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 6.1% | 3,407,969 | 0 | 3,407,969 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 6.1% | 3,407,969 | 0 | 3,407,969 | /s/ Israel A. Englander | Israel A. Englander |